Skip to main content

OrbiMed Advisors LLC's Form 4 filing

Alpine Immune Sciences, Inc. (ALPN) · filed Dec 29, 2023

Accession no.
0000947871-23-001189
Filed
Dec 29, 2023, 4:18 PM ET
Trade date
Dec 27-28, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 6 non-derivative transactions. Open-market sales total $28.7M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
OrbiMed Advisors LLCCIK 0001055951Director
OrbiMed Capital GP VI LLCCIK 0001682115Director
OrbiMed Genesis GP LLCCIK 0001808744Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 27, 2023Common StockSSaleDisposed−162,576$19.96−$3,245,016.963,493,485IndirectDuplicate filing
Dec 27, 2023Common StockSSaleDisposed−18,922$19.96−$377,683.12406,609IndirectDuplicate filing
Dec 28, 2023Common StockSSaleDisposed−26,872$19.82−$532,603.043,466,613IndirectDuplicate filing
Dec 28, 2023Common StockSSaleDisposed−3,128$19.82−$61,996.96403,481IndirectDuplicate filing
Dec 28, 2023Common StockSSaleDisposed−1,195,683$18.32−$21,904,912.562,270,930IndirectDuplicate filing
Dec 28, 2023Common StockSSaleDisposed−139,166$18.32−$2,549,521.12264,315IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)